Cary Street Partners Financial LLC Halozyme Therapeutics, Inc. Transaction History
Cary Street Partners Financial LLC
- $3.07 Trillion
- Q4 2024
A detailed history of Cary Street Partners Financial LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Cary Street Partners Financial LLC holds 99,154 shares of HALO stock, worth $5.74 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
99,154Holding current value
$5.74 Million% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
545Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.02 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$769 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$416 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$241 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$200 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.06B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...